In tumor-inhibiting conditions, exosomal miR-320a targets PBX Homeobox 3 (PBX3) in recipient cells, resulting in a reduction of phosphor-ERK1/2 and N-cadherin as well, as an increase of E-cadherin. This evidence concerns the gene PBX3 and neoplasm.